I’m excited for this one! On November 4th, JAMA Psychiatry published a study with an impressive claim: psilocybin was (get this) at least 4 times more effective on major depression than the usual antidepressants. Plant medicine is a big fascination for me, so it was so rewarding to speak with one of the authors that study, Dr. Alan K Davis. Alan is on the bleeding edge of both the research and the practical treatment at Johns Hopkins, and we talk about how the study was set up, the barriers involved, the effects on the patients, and some of the upcoming (and promising) studies in the pipeline.

Dr. Alan K Davis is an Assistant Professor of Social Work at The Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Dr. Davis’s clinical experience includes working with people diagnosed with trauma-based psychological problems such as addiction, PTSD, depression, and anxiety. His clinical expertise includes providing evidenced-based treatments such as motivational interviewing, cognitive behavioral therapy, acceptance and commitment therapy, and psilocybin-assisted psychotherapy. Consistent with his clinical interests, his research interests and expertise focus on contributing to the knowledge of and ability to help those suffering with substance use and mental health problems, understanding how to improve clinical outcomes through examining new treatments, and developing ways to conceptualize substance use and mental health problems through a strengths-based approach. He recently completed a clinical trial of psilocybin therapy for major depressive disorder and current trials include exploring this treatment for patients with co-occurring alcohol use disorder and depression and patients with anorexia. He actively explores topics related to naturalistic psychedelic use among several populations including people of color who have experienced racial trauma, Spanish-speaking people, and people who use novel psychedelics such as 5-MeO-DMT. 

 

Connect with Alan:

-Ohio State University

-Johns Hopkins Center for Psychedelic and Consciousness Research

-Source Research Foundation (grants and support for students)

Are you looking to find your purpose, navigate transition, or fix your relationships, all with a powerful group of men from around the world? Check out The Alliance and join me today. 

Check out our Facebook Page or the Men's community.

Subscribe on Apple Podcasts | Google Podcasts  | Spotify

For more episodes visit us at ManTalks.com | Facebook | Instagram | Twitter   

Did you enjoy the podcast? If so, please leave us a review on Apple Podcasts or Stitcher. It helps our podcast get into the ears of new listeners, which expands the ManTalks Community

Editing & Mixing by: Aaron The Tech

I&rsquo;m excited for this one! On November 4th, JAMA Psychiatry published a study with an impressive claim: psilocybin was (get this) at least 4 times more effective on major depression than the usual antidepressants. Plant medicine is a big fascination for me, so it was so rewarding to speak with one of the authors that study, Dr. Alan K Davis. Alan is on the bleeding edge of both the research and the practical treatment at Johns Hopkins, and we talk about how the study was set up, the barriers involved, the effects on the patients, and some of the upcoming (and promising) studies in the pipeline.
Dr. Alan K Davis is an Assistant Professor of Social Work at The Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Dr. Davis&rsquo;s clinical experience includes working with people diagnosed with trauma-based psychological problems such as addiction, PTSD, depression, and anxiety. His clinical expertise includes providing evidenced-based treatments such as motivational interviewing, cognitive behavioral therapy, acceptance and commitment therapy, and psilocybin-assisted psychotherapy. Consistent with his clinical interests, his research interests and expertise focus on contributing to the knowledge of and ability to help those suffering with substance use and mental health problems, understanding how to improve clinical outcomes through examining new treatments, and developing ways to conceptualize substance use and mental health problems through a strengths-based approach. He recently completed a clinical trial of psilocybin therapy for major depressive disorder and current trials include exploring this treatment for patients with co-occurring alcohol use disorder and depression and patients with anorexia. He actively explores topics related to naturalistic psychedelic use among several populations including people of color who have experienced racial trauma, Spanish-speaking people, and people who use novel psychedelics such as 5-MeO-DMT.&nbsp;
&nbsp;
Connect with Alan:
-<a href="https://csw.osu.edu/about/faculty-staff/faculty-directory/davis-alan/">Ohio State University</a>
-<a href="https://hopkinspsychedelic.org/davis">Johns Hopkins Center for Psychedelic and Consciousness Research</a>
-<a href="https://www.sourceresearchfoundation.org/">Source Research Foundation</a> (grants and support for students)
<hr>
Are you looking to find your purpose, navigate transition, or fix your relationships, all with a powerful group of men from around the world? Check out <a href="https://mantalks.com/the-alliance">The Alliance</a> and join me today.&nbsp;
Check out our <a href="https://www.facebook.com/ManTalks.ca/">Facebook Page</a> or the <a href="https://www.facebook.com/groups/ManTalksCommunity/">Men's community</a>.
Subscribe on <a href="https://itunes.apple.com/us/podcast/mantalks-podcast-inspiring/id1015078747?mt=2">Apple Podcasts</a> | <a href="https://mantalks.com/googlepodcasts">Google Podcasts</a>&nbsp; | <a href="https://open.spotify.com/show/7pERITPtcg832IOwgZCF6x?si=7cgdOfmNQ8u2rZ4ovTP92A">Spotify</a>
For more episodes visit us at <a href="https://mantalks.com/">ManTalks.com</a> | <a href="https://www.facebook.com/ManTalks.ca/">Facebook</a> | <a href="https://www.instagram.com/mantalks/?hl=en">Instagram</a> | <a href="https://twitter.com/mantalks">Twitter</a>&nbsp;&nbsp;&nbsp;
Did you enjoy the podcast? If so, please leave us a review on <a href="https://mantalks.com/applepodcasts">Apple Podcasts</a> or <a href="https://www.stitcher.com/podcast/the-mantalks-podcast">Stitcher</a>. It helps our podcast get into the ears of new listeners, which expands the <a href="https://mantalks.com/">ManTalks Community</a>
Editing &amp; Mixing by: <a href="https://aaronthe.tech/">Aaron The Tech</a>

The ManTalks podcast features conversations between one of the leading men’s work facilitators and philosopher, Connor Beaton, and world class guests with expertise in mindset, life purpose, psychology, relational communication, sexual intimacy, business and spirituality. 

For more information about ManTalks go to: http://www.mantalks.com

The ManTalks podcast features conversations between one of the leading men&rsquo;s work facilitators and philosopher, Connor Beaton, and world class guests with expertise in mindset, life purpose, psychology, relational communication, sexual intimacy, business and spirituality.&nbsp;
For more information about ManTalks go to: http://www.mantalks.com

Creating better men through Conversation, Connection and Community

ManTalks Podcast

Dr. Alan K Davis is an Assistant Professor of Social Work at The Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Dr. Davis’s clinical experience includes working with people diagnosed with trauma-based psychological problems such as addiction, PTSD, depression, and anxiety. His clinical expertise includes providing evidenced-based treatments such as motivational interviewing, cognitive behavioral therapy, acceptance and commitment therapy, and psilocybin-assisted psychotherapy. Consistent with his clinical interests, his research interests and expertise focus on contributing to the knowledge of and ability to help those suffering with substance use and mental health problems, understanding how to improve clinical outcomes through examining new treatments, and developing ways to conceptualize substance use and mental health problems through a strengths-based approach. He recently completed a clinical trial of psilocybin therapy for major depressive disorder and current trials include exploring this treatment for patients with co-occurring alcohol use disorder and depression and patients with anorexia. He actively explores topics related to naturalistic psychedelic use among several populations including people of color who have experienced racial trauma, Spanish-speaking people, and people who use novel psychedelics such as 5-MeO-DMT.

Advertisement